Humedix Co., Ltd. (KOSDAQ: 200670)
South Korea flag South Korea · Delayed Price · Currency is KRW
25,550
-900 (-3.40%)
Nov 14, 2024, 9:00 AM KST

Humedix Statistics

Total Valuation

Humedix has a market cap or net worth of KRW 299.38 billion.

Market Cap 299.38B
Enterprise Value n/a

Important Dates

The last earnings date was Tuesday, November 12, 2024.

Earnings Date Nov 12, 2024
Ex-Dividend Date Jun 27, 2024

Share Statistics

Humedix has 10.40 million shares outstanding.

Current Share Class n/a
Shares Outstanding 10.40M
Shares Change (YoY) n/a
Shares Change (QoQ) +0.00%
Owned by Insiders (%) 1.59%
Owned by Institutions (%) 8.02%
Float 6.18M

Valuation Ratios

The trailing PE ratio is 29.88 and the forward PE ratio is 6.95.

PE Ratio 29.88
Forward PE 6.95
PS Ratio 2.44
PB Ratio 2.15
P/TBV Ratio n/a
P/FCF Ratio 55.02
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.06, with a Debt / Equity ratio of 0.23.

Current Ratio 3.06
Quick Ratio 2.00
Debt / Equity 0.23
Debt / EBITDA 1.16
Debt / FCF 6.02
Interest Coverage 7.16

Financial Efficiency

Return on equity (ROE) is 7.26% and return on invested capital (ROIC) is 6.05%.

Return on Equity (ROE) 7.26%
Return on Assets (ROA) 5.11%
Return on Capital (ROIC) 6.05%
Revenue Per Employee 447.55M
Profits Per Employee 36.55M
Employee Count 248
Asset Turnover 0.57
Inventory Turnover 3.77

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -24.07% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -24.07%
50-Day Moving Average 32,258.00
200-Day Moving Average 32,058.75
Relative Strength Index (RSI) 30.68
Average Volume (20 Days) 118,953

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Humedix had revenue of KRW 110.99 billion and earned 9.06 billion in profits. Earnings per share was 963.99.

Revenue 110.99B
Gross Profit 44.07B
Operating Income 15.99B
Pretax Income 11.34B
Net Income 9.06B
EBITDA 28.26B
EBIT 15.99B
Earnings Per Share (EPS) 963.99
Full Income Statement

Balance Sheet

The company has 54.35 billion in cash and 32.73 billion in debt, giving a net cash position of 21.62 billion or 2,079.87 per share.

Cash & Cash Equivalents 54.35B
Total Debt 32.73B
Net Cash 21.62B
Net Cash Per Share 2,079.87
Equity (Book Value) 141.95B
Book Value Per Share 13,398.54
Working Capital 79.77B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 19.18 billion and capital expenditures -13.74 billion, giving a free cash flow of 5.44 billion.

Operating Cash Flow 19.18B
Capital Expenditures -13.74B
Free Cash Flow 5.44B
FCF Per Share 523.45
Full Cash Flow Statement

Margins

Gross margin is 39.70%, with operating and profit margins of 14.41% and 8.17%.

Gross Margin 39.70%
Operating Margin 14.41%
Pretax Margin 10.22%
Profit Margin 8.17%
EBITDA Margin 25.46%
EBIT Margin 14.41%
FCF Margin 4.90%

Dividends & Yields

This stock pays an annual dividend of 550.00, which amounts to a dividend yield of 2.08%.

Dividend Per Share 550.00
Dividend Yield 2.08%
Dividend Growth (YoY) -23.33%
Years of Dividend Growth n/a
Payout Ratio 41.51%
Buyback Yield 1.06%
Shareholder Yield 3.14%
Earnings Yield 3.35%
FCF Yield 1.82%
Dividend Details

Stock Splits

The last stock split was on December 27, 2018. It was a forward split with a ratio of 1.07.

Last Split Date Dec 27, 2018
Split Type Forward
Split Ratio 1.07

Scores

Humedix has an Altman Z-Score of 3.88.

Altman Z-Score 3.88
Piotroski F-Score n/a